Brief: Bellus Health Reports Second Quarter 2022 Financial Results And Business Highlights
10/08/2022 21:34
Aug 10 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
* BELLUS HEALTH INC - CASH RUNWAY EXTENDED TO 2H 2025 AND
THROUGH
TOPLINE RESULTS OF BOTH CALM-1 AND CALM-2 TRIALS
* BELLUS HEALTH INC - ENDED Q2 2022 WITH APPROXIMATELY
US$384.6
MILLION IN PRO-FORMA CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS
* BELLUS HEALTH INC - QTRLY LOSS PER SHARE $0.18
Source text for Eikon: ID:nBw7lp6bYa
Further company coverage: BLU.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln